Target-decorating of tumors potentiates chimeric antigen receptor-T cell therapy

被引：0
|
作者：
Meng, F.
Shen, Y.
Tan, S.
Shao, J.
Qian, H.
Sha, H.
Xu, Q.
Du, J.
Yan, J.
Zou, Z.
Wei, J.
Liu, B.
机构：
[1] Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P0504
引用
收藏
页码：1713 / 1714
页数：2
相关论文
共 50 条
  • [11] Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies
    Yang Zhihuan
    Wang Ying
    中华医学杂志英文版, 2023, 136 (19)
  • [12] Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
    Totzeck, Matthias
    Michel, Lars
    Lin, Yi
    Herrmann, Joerg
    Rassaf, Tienush
    EUROPEAN HEART JOURNAL, 2022, 43 (20) : 1928 - 1940
  • [13] The update of chimeric antigen receptor-T cells therapy in glioblastoma
    Chou, Chi-Jen
    Lin, Chun-Fu
    Chen, Yi-Wei
    Huang, Pin-, I
    Yang, Yi-Ping
    Wang, Mong-Lien
    Hung, Kai-Feng
    Lee, Yi-Yen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 442 - 445
  • [14] Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma
    Kuroda, Hideki
    Kijima, Noriyuki
    Tachi, Tetsuro
    Ikeda, Shunya
    Murakami, Koki
    Nakagawa, Tomoyoshi
    Yaga, Moto
    Nakagawa, Kanji
    Utsugi, Reina
    Hirayama, Ryuichi
    Okita, Yoshiko
    Kagawa, Naoki
    Hosen, Naoki
    Kishima, Haruhiko
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [15] Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy
    Sterner, Robert. C. C.
    Sterner, Rosalie. M. M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [16] Chimeric antigen receptor-T cell therapies: The changing landscape
    Sengsayadeth, Salyka M.
    Dholaria, Bhagirathbhai R.
    Savani, Bipin N.
    Oluwole, Olalekan O.
    EJHAEM, 2022, 3 : 3 - 5
  • [17] Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions
    Benevolo Savelli, Corrado
    Clerico, Michele
    Botto, Barbara
    Secreto, Carolina
    Cavallo, Federica
    Dellacasa, Chiara
    Busca, Alessandro
    Bruno, Benedetto
    Freilone, Roberto
    Cerrano, Marco
    Novo, Mattia
    Tzachanis, Dimitrios
    Jeong, Ah-Reum
    CANCERS, 2024, 16 (01)
  • [18] Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
    Katopodi, Theodora
    Petanidis, Savvas
    Anestakis, Doxakis
    Charalampidis, Charalampos
    Chatziprodromidou, Ioanna
    Floros, George
    Eskitzis, Panagiotis
    Zarogoulidis, Paul
    Koulouris, Charilaos
    Sevva, Christina
    Papadopoulos, Konstantinos
    Dagher, Marios
    Varsamis, Nikolaos
    Theodorou, Vasiliki
    Mystakidou, Chrysi Maria
    Katsios, Nikolaos Iason
    Farmakis, Konstantinos
    Kosmidis, Christoforos
    PHARMACEUTICS, 2023, 15 (10)
  • [19] A Novel Treatment for Ewing's Sarcoma: Chimeric Antigen Receptor-T Cell Therapy
    Lin, Zili
    Wu, Ziyi
    Luo, Wei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [20] Cardiovascular Complications of CD 19 Chimeric Antigen Receptor-T Cell Therapy: A Systematic Review
    Shahzad, Moazzam
    Munir, Farrukh
    Khan, Junaid
    Khalid, Muhammad Fareed
    Abbas, Sakina
    Javaid, Hafiza Wajeeha
    Chattha, Suneeba Javed
    Ahmed, Mamoon
    Faisal, Muhammad Salman
    Anwar, Iqra
    Chaudhary, Sibgha Gull
    Mushtaq, Muhammad Umair
    BLOOD, 2022, 140 : 12768 - 12769
12345